House of Lords Business
Show full summary

Lord Selkirk of Douglas to ask His Majesty's Government when patient organisations such as Cystic Fibrosis Trust, whose Clinical Trials Accelerator Platform informed the design of Clinical Trial Acceleration Networks, will be able to share lessons to feed into the implementation update for the O'Shaughnessy Review.  HL8849

Question HL8849: tabled on 27 June 2023 and due for answer by 11 July 2023

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Selkirk of Douglas to ask His Majesty's Government when patient organisations such as Cystic Fibrosis Trust, whose Clinical Trials Accelerator Platform informed the design of Clinical Trial Acceleration Networks, will be able to share lessons to feed into the implementation update for the O'Shaughnessy Review.  HL8849
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Selkirk of Douglas
Conservative
Life peer